Skip to main content

Genocea Biosciences, Inc.

GNCADelisted Jun 2, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001457612

Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in Genocea Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−6 vs. Q2 2021
Shares held
34.0M
+87.9K (+0.3%) vs. Q2 2021
Total value
$65.3M
−$14.1M (−17.7%) vs. Q2 2021
New holders
2
12 more added
Sold out
8
8 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 40 institutions
Q1 2021: 42 institutionsQ2 2021: 46 institutionsQ3 2021: 40 institutionsQ4 2021: 41 institutionsQ1 2022: 40 institutionsQ2 2022: 5 institutionsQ3 2022: 1 institutionQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ3 2021: $65.3M
Q1 2021: $86.3MQ2 2021: $79.4MQ3 2021: $65.3MQ4 2021: $38.9MQ1 2022: $42.1MQ2 2022: $92.0KQ3 2022: $4.00KQ4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $1Q1 2024: $0Q2 2024: $0Q3 2024: $1Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding GNCA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$0
Q4 20251$0
Q3 20250$0
Q2 20250$0
Q1 20251$0
Q4 20241$0
Q3 20241$1
Q2 20241$0
Q1 20241$0
Q4 20231$1
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20221$4.00K
Q2 20225$92.0K
Q1 202240$42.1M
Q4 202141$38.9M
Q3 202140$65.3M
Q2 202146$79.4M
Q1 202142$86.3M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q2 2021.

Institutions holding GNCA in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC10,376,936$19.9M0.25%00.0%Unchanged
Avoro Capital Advisors LLC5,084,184$9.76M0.15%00.0%Unchanged
BVF Inc4,012,404$7.70M0.30%00.0%Unchanged
Commodore Capital LP3,079,756$5.91M1.56%+150,309+5.1%Added
Point72 Asset Management, L.P.2,652,974$5.09M0.02%+152,974+6.1%Added
Kingdon Capital Management, L.L.C.1,972,056$3.79M0.66%00.0%Unchanged
Citadel Advisors LLC1,853,826$3.56M0.00%−18,410−1.0%Reduced
Vanguard Group Inc1,563,101$3.00M0.00%+24,638+1.6%Added
Boxer Capital, LLC1,134,453$2.18M0.08%00.0%Unchanged
Millennium Management LLC377,345$725.0K0.00%+91,304+31.9%Added
ABG Innovation Capital Partners III GP Ltd375,000$720.0K29.91%00.0%Unchanged
HighTower Advisors, LLC212,260$408.0K0.00%−100.0%Reduced
Polaris Venture Management Co. V, L.L.C.197,345$379.0K2.69%00.0%Unchanged
Ikarian Capital, LLC196,821$377.0K0.09%−3,179−1.6%Reduced
Geode Capital Management, LLC185,942$357.0K0.00%+6,228+3.5%Added
BlackRock Inc.180,991$347.0K0.00%+2,019+1.1%Added
Two Sigma Advisers, LP142,477$274.0K0.00%−106,000−42.7%Reduced
Group One Trading, L.P.61,614$118.0K0.00%+41,939+213.2%Added
Two Sigma Investments, LP57,836$111.0K0.00%−96,611−62.6%Reduced
Bank of America Corp57,363$110.0K0.00%+177+0.3%Added
Northern Trust Corp56,469$108.0K0.00%+16,587+41.6%Added
Commonwealth Equity Services, LLC21,405$41.0K0.00%+700+3.4%Added
Boothbay Fund Management, LLC19,916$38.0K0.00%−3,179−13.8%Reduced
State Street Corp19,684$38.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp16,305$31.0K0.00%00.0%Unchanged
Morgan Stanley15,669$30.0K0.00%−835−5.1%Reduced
Personal Capital Advisors Corp15,000$29.0K0.00%00.0%Unchanged
WealthTrust Axiom LLC15,000$28.0K0.01%00.0%Unchanged
First Republic Investment Management, Inc.12,285$24.0K0.00%00.0%Unchanged
Capital Asset Advisory Services LLC11,766$23.0K0.00%00.0%Unchanged
Wells Fargo & Company9,668$18.0K0.00%+136+1.4%Added
Vectors Research Management, LLC6,000$12.0K0.00%+1,000+20.0%Added
Tower Research Capital LLC (TRC)5,902$11.0K0.00%−2,672−31.2%Reduced
ACT Capital Management, LLC5,000$10.0K0.01%00.0%Unchanged
First Manhattan Co2,500$4.00K0.00%00.0%Unchanged
Artemis Wealth Advisors, LLC1,137$2.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.800$2.00K0.00%00.0%Unchanged
Federated Hermes, Inc.1,037$2.00K0.00%+1,037New
Cutler Group LP900$1.00K0.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co625$1.00K0.00%+625New
Diametric Capital, LP0$00.00%−69,977−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−43,643−100.0%Sold out
UBS Oconnor LLC0$00.00%−19,170−100.0%Sold out
Virtu Financial LLC0$00.00%−15,625−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−11,131−100.0%Sold out
Pinz Capital Management, LP0$00.00%−7,200−100.0%Sold out
UBS Group AG0$00.00%−3,834−100.0%Sold out
Citigroup Inc0$00.00%−250−100.0%Sold out